Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.
- DOI
- 10.1245/s10434-025-18196-7
- Published
- 2025 Dec
- Container
- Annals of surgical oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1245/s10434-025-18196-7,
title = {Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.},
author = {Péron J and Essadi I and Rousset P and Villeneuve L and Benzerdjeb N and Goéré D and Sourrouille I and Sgarbura O and Ferron G and Pocard M and Dumont F and Bereder JM and Brigand C and Glehen O and Kepenekian V and RENAPE},
year = {2025},
journal = {Annals of surgical oncology},
doi = {10.1245/s10434-025-18196-7},
url = {https://doi.org/10.1245/s10434-025-18196-7}
}RIS
TY - JOUR TI - Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients. AU - Péron J AU - Essadi I AU - Rousset P AU - Villeneuve L AU - Benzerdjeb N AU - Goéré D AU - Sourrouille I AU - Sgarbura O AU - Ferron G AU - Pocard M AU - Dumont F AU - Bereder JM AU - Brigand C AU - Glehen O AU - Kepenekian V AU - RENAPE PY - 2025 JO - Annals of surgical oncology DO - 10.1245/s10434-025-18196-7 UR - https://doi.org/10.1245/s10434-025-18196-7 ER -
APA
J, P., I, E., P, R., L, V., N, B., D, G., I, S., O, S., G, F., M, P., F, D., JM, B., C, B., O, G., V, K., & RENAPE (2025). Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.. Annals of surgical oncology. https://doi.org/10.1245/s10434-025-18196-7
Source records
- pubmed · retrieved 2026-09-27T00:21:59.760Z
- europe-pmc · retrieved 2026-09-27T00:21:59.780Z
- hal · retrieved 2026-09-27T00:21:59.793Z